Kathy High leads GV, ARCH-backed eye disease biotech; Arvinas commercial exec steps down

→ Spark co-founder Kathy High made a quiet return to eye disease drug development, becoming CEO of US-Swiss biotech RhyGaze “late last year,” the Philadelphia Business Journal reported this week. RhyGaze ...